Strong returns in IM Nailing and a flurry of activity in the Pediatric space results in a healthy Q123 for the Trauma Market
The US Trauma Market grew +6.0% in Q123 fueled by new product adoption. While headwinds such as supply chain constraints, economic challenges and staffing shortages could darken the forecast,
SmartTRAK expects the Trauma Market will not be as heavily impacted as its elective procedure counterparts and should continue to experience healthy growth through 2023 as many manufacturers note Q1 results are in line with pre-Covid historical trends.
Among the many topics covered in detail in
SmartTRAK
's comprehensive
Q123 Trauma Market Recap
*
are:
- Complete Q123 Trauma Market Overview
- SmartTRAK's Expert Market Analysis and Insights
- All Trauma Companies' News, Revenues, Data, Charts and Market Shares
- IM Nailing Closes the Quarter on High with Solid Returns
- New Regulatory Clearances Propel the Pediatric Trauma Segment:
- OrthoPediatrics
- NuVasive Specialized Orthopedics, Inc.
- Wishbone Medical
- Q123 Trauma Regulatory Highlights
During Q1, the Pediatric Trauma segment experienced a notable surge in regulatory clearances, indicating forthcoming product launches aimed at bolstering the segment's growth. These approvals signal ...
Read the entire Q123 Trauma Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares*
*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below. 
